Build your career on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.
Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.
Kite is seeking a highly motivated individual to join us as an Associate II, Project Management, to work in the exciting area of cancer immunotherapy. This position will provide project management and regulatory filing support to the global Regulatory CMC team in a dynamic and fast paced organization and contribute to the timely execution of CMC strategy in a cell therapy setting. The preferred candidate will possess strong interpersonal skills as this position interacts with all levels of employees in Technical Operations (Process Development, Quality, Supply Chain, Manufacturing), and Regulatory Affairs across multiple geographies.
Responsibilities:
Requirements:
Additional qualifications and information:
Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors.
For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago.
View what's on offer:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.